Andrew Joe

Andrew Joe

Chief Tech/Sci/R&D Officer chez MERUS N.V.

Fortune : - $ au 31/03/2024

58 ans
Finance
Consumer Services
Health Technology

Provenance du réseau au premier degré de Andrew Joe

EntitéType d'entitéIndustrie
Public Company Biotechnology 20

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Andrew Joe via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Pharmaceuticals: Major

Bill Lundberg

Chief Tech/Sci/R&D Officer

Biotechnology

Len Kanavy

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Bill Lundberg

Corporate Officer/Principal

Rochester Christian University College/University

Peter Silverman

Undergraduate Degree

Medical Specialties

Bill Lundberg

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Antisoma Research Ltd.

Bill Lundberg

Corporate Officer/Principal

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

KALA BIO, INC. Pharmaceuticals: Major

Gregory Perry

Mark Iwicki

Director/Board Member

Chief Executive Officer

Biotechnology

Mark Iwicki

Director/Board Member

ACLARIS THERAPEUTICS, INC. Pharmaceuticals: Major

Maxine Gowen

Anand Mehra

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Miscellaneous Commercial Services

Peter Silverman

Corporate Officer/Principal

Investment Managers

Mark Iwicki

Consultant / Advisor

College/University

Mark Throsby

Doctorate Degree

College/University

Sherri L. Spear

Undergraduate Degree

Loyola University Maryland, Inc. College/University

Mark Iwicki

Masters Business Admin

University of Michigan College/University

Liu Hui

Doctorate Degree

University of Scranton College/University

Len Kanavy

Masters Business Admin

Pharmaceuticals: Major

Mark Iwicki

Corporate Officer/Principal

University of Utrecht College/University

John de Kruif

Cecilia Anna Wilhelmina Geuijen

Doctorate Degree

Doctorate Degree

Investment Banks/Brokers

Sherri L. Spear

Analyst-Equity

Stanford University School of Medicine College/University

Bill Lundberg

Doctorate Degree

Fordham University School of Law College/University

Peter Silverman

Graduate Degree

CRISPR THERAPEUTICS AG Biotechnology

Bill Lundberg

Chief Tech/Sci/R&D Officer

PULMATRIX, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Biotechnology

Mark Iwicki

Bill Lundberg

Chairman

Director/Board Member

Pharmaceuticals: Major

Mark Throsby

Director/Board Member

Medical Specialties

Mark Throsby

Chief Operating Officer

THIRD HARMONIC BIO, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

AEROVATE THERAPEUTICS, INC. Biotechnology

Mark Iwicki

Director/Board Member

AKERO THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

RALLYBIO CORPORATION Biotechnology

Liu Hui

Director/Board Member

Statistiques

Internationale

Etats-Unis 36
Pays-Bas 4
Royaume-Uni 3
Australie 2
Suisse 2

Sectorielle

Health Technology 25
Consumer Services 10
Finance 7
Commercial Services 4

Opérationnelle

Director/Board Member 72
Corporate Officer/Principal 37
Independent Dir/Board Member 37
Director of Finance/CFO 12
Doctorate Degree 11
  1. Bourse
  2. Insiders
  3. Andrew Joe
  4. Connexions Sociétés